VEGF is a potential mediator of pulmonary vascular remodeling, and its expression increases in the airway of bronchitis-type patients, leading to abnormal proliferation of endothelial and vascular smooth muscle cells in pulmonary vessels [34]. Here, VEGFA is linked to bronchial disorder.